MUMBAI – The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report ...
MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd has been warned by U.S. health regulators for violating manufacturing standards at its Halol plant in India, even as it ...
Sun Pharma’s share price continues to be under pressure and is down 2% in trade today. Nomura maintained its ‘Neutral’ rating on the stock and retained a target price of Rs 1,970 per share. This ...
MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results